Found: 6
Select item for more details and to access through your institution.
Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39122-z
- By:
- Publication type:
- Article
INHBA is a mediator of aggressive tumor behavior in HER2+ basal breast cancer.
- Published in:
- Breast Cancer Research, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13058-022-01512-4
- By:
- Publication type:
- Article
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CA.
- Published in:
- 2021
- By:
- Publication type:
- journal article
VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase.
- Published in:
- FASEB Journal, 2008, v. 22, n. 9, p. 3264, doi. 10.1096/fj.08-106468
- By:
- Publication type:
- Article
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-78798-x
- By:
- Publication type:
- Article
Akt3 controls vascular endothelial growth factor secretion and angiogenesis in ovarian cancer cells.
- Published in:
- International Journal of Cancer, 2012, v. 130, n. 3, p. 532, doi. 10.1002/ijc.26010
- By:
- Publication type:
- Article